237 related articles for article (PubMed ID: 35447246)
1. Overview of advances in CRISPR/deadCas9 technology and its applications in human diseases.
Kanafi MM; Tavallaei M
Gene; 2022 Jul; 830():146518. PubMed ID: 35447246
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants.
Ding X; Yu L; Chen L; Li Y; Zhang J; Sheng H; Ren Z; Li Y; Yu X; Jin S; Cao J
Cells; 2022 Sep; 11(19):. PubMed ID: 36231007
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/dCas system as the modulator of gene expression.
Kazi TA; Biswas SR
Prog Mol Biol Transl Sci; 2021; 178():99-122. PubMed ID: 33685602
[TBL] [Abstract][Full Text] [Related]
4. Points of View on the Tools for Genome/Gene Editing.
Chuang CK; Lin WM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
[TBL] [Abstract][Full Text] [Related]
5. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
Sharma S; Sharma CM
Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
[TBL] [Abstract][Full Text] [Related]
6. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
8. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation.
Cai R; Lv R; Shi X; Yang G; Jin J
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834313
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing.
Moradpour M; Abdulah SNA
Plant Biotechnol J; 2020 Jan; 18(1):32-44. PubMed ID: 31392820
[TBL] [Abstract][Full Text] [Related]
11. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
Neldeborg S; Lin L; Stougaard M; Luo Y
Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
13. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
[TBL] [Abstract][Full Text] [Related]
14. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
15. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
[TBL] [Abstract][Full Text] [Related]
16. Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems.
Wu H; Liu Q; Shi H; Xie J; Zhang Q; Ouyang Z; Li N; Yang Y; Liu Z; Zhao Y; Lai C; Ruan D; Peng J; Ge W; Chen F; Fan N; Jin Q; Liang Y; Lan T; Yang X; Wang X; Lei Z; Doevendans PA; Sluijter JPG; Wang K; Li X; Lai L
Cell Mol Life Sci; 2018 Oct; 75(19):3593-3607. PubMed ID: 29637228
[TBL] [Abstract][Full Text] [Related]
17. CRISPR Mediated Genome Engineering and its Application in Industry.
Kaboli S; Babazada H
Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
Markus BM; Boydston EA; Lourido S
mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
[TBL] [Abstract][Full Text] [Related]
19. [Development of CRISPR technology and its application in bone and cartilage tissue engineering].
Chen G; Cheng D; Chen B
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1515-1520. PubMed ID: 31907146
[TBL] [Abstract][Full Text] [Related]
20. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.
Yang Y; Li D; Wan F; Chen B; Wu G; Li F; Ren Y; Liang P; Wan J; Songyang Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
